C–11 Methionine Uptake in Granulomatous DiseaseHain, Sharon F., MBBS, FRACP; Beggs, Andrew D., MBBS, BScClinical Nuclear Medicine: September 2004 - Volume 29 - Issue 9 - p 585-586 doi: 10.1097/01.rlu.0000134997.91642.56 Interesting Image Buy Abstract Author InformationAuthors Article MetricsMetrics Although uptake of F-18 FDG is well documented in granulomatous disease, there is little literature available regarding C-11 methionine positron emission tomography (PET) in these conditions. We present a case in which C-11 methionine imaging was performed for localization of a probable parathyroid adenoma, but other areas of uptake identified were subsequently found to be the result of sarcoidosis. Clinicians must therefore take care when interpreting C-11 methionine PET scans because granulomatous disease could cause false-positives. From The Clinical PET Centre, Guys & St. Thomas’ Hospitals, Lambeth Palace Road, London, UK. Received for publication September 3, 2003; revision accepted December 23, 2003. Reprints: Sharon F. Hain, MBBS, FRACP, The Clinical PET Centre, Guys & St. Thomas’ Hospitals, Lambeth Palace Road, London, SE1 7EH, UK. E-mail: email@example.com © 2004 Lippincott Williams & Wilkins, Inc.